Week 96 Efficacy and Safety Results of Tenofovir Alafenamide (TAF) Comparing to Tenofovir Disoproxil Fumarate (TDF) in Chronic Hepatitis B (CHB), HBEAG-Positive Patients: A Global Phase 3 Study
| Autor: | Mani Subramanian, John F. Flaherty, Wan-Long Chuang, Scott Fung, Norihiro Furusyo, Edward Gane, Kosh Agarwal, Ki Tae Yoon, Shalimar, Ho Bae, Lanjia Lin, Alain Chan, Wai-Kay Seto, Harry L.A. Janssen, Young-Suk Lim, Audrey H. Lau, Anuj Gaggar, Vithika Suri, Henry L. Chan, Andrea L. Cathcart, Maria Buti |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
HBEAG POSITIVE
medicine.medical_specialty Hepatology Tenofovir business.industry Gastroenterology Phases of clinical research Tenofovir alafenamide 03 medical and health sciences 0302 clinical medicine Chronic hepatitis 030220 oncology & carcinogenesis Internal medicine medicine 030211 gastroenterology & hepatology business medicine.drug |
| Zdroj: | Gastroenterology. 152:S1085-S1086 |
| ISSN: | 0016-5085 |
| DOI: | 10.1016/s0016-5085(17)33660-0 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|